We are live on
!
Find out more
ACM
Argyle Capital Management Portfolio holdings
AUM
$347M
1-Year Est. Return
44.33%
This Fund
S&P 500
This Quarter
Est. Return
+0.84%
1 Year Est. Return
+44.33%
3 Year Est. Return
+95.77%
5 Year Est. Return
+124.66%
10 Year Est. Return
+325.03%
AUM
$174M
AUM Growth
–
Cap. Flow
+$176M
Cap. Flow
% of AUM
100.96%
Top 10 Holdings %
Top 10 Hldgs %
24.86%
Holding
108
New
108
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$4.91M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$4.88M |
| 3 |
Merck
MRK
|
+$4.75M |
| 4 |
Verizon
VZ
|
+$4.67M |
| 5 |
AT&T
T
|
+$4.31M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.77% |
| 2 | Technology | 14.15% |
| 3 | Industrials | 11.26% |
| 4 | Energy | 10.86% |
| 5 | Consumer Staples | 8.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Eli Lilly
LLY
$1.02T
| $2.75M | 1.57% |
+55,899
| New | +$3.04M |
|
|
CB
27
DELISTED
CHUBB CORPORATION
CB
| $2.65M | 1.52% |
+31,250
| New | +$2.73M |
|
|
EMC
28
DELISTED
EMC CORPORATION
EMC
| $2.64M | 1.51% |
+111,610
| New | +$2.63M |
|
29
Baxter International
BAX
$13.5B
| $2.58M | 1.48% |
+68,631
| New | +$2.63M |
|
30
Procter & Gamble
PG
$336B
| $2.58M | 1.48% |
+33,503
| New | +$2.63M |
|
31
Conagra Brands
CAG
$6.94B
| $2.48M | 1.42% |
+91,261
| New | +$2.47M |
|
32
Waste Management
WM
$90.6B
| $2.28M | 1.31% |
+56,600
| New | +$2.29M |
|
33
Waters Corp
WAT
$37B
| $2.06M | 1.18% |
+20,550
| New | +$1.97M |
|
|
PCL
34
DELISTED
PLUM CREEK TIMBER CO (REIT)
PCL
| $2.05M | 1.18% |
+43,925
| New | +$2.21M |
|
|
CSC
35
DELISTED
Computer Sciences
CSC
| $2.02M | 1.16% |
+109,633
| New | +$2.11M |
|
36
Comcast
CMCSA
$85B
| $1.95M | 1.11% |
+93,164
| New | +$1.92M |
|
37
BP
BP
$116B
| $1.91M | 1.09% |
+55,912
| New | +$1.95M |
|
|
DD
38
DELISTED
Du Pont De Nemours E I
DD
| $1.91M | 1.09% |
+38,222
| New | +$1.93M |
|
39
Halliburton
HAL
$26.9B
| $1.89M | 1.08% |
+45,300
| New | +$1.89M |
|
40
Cisco
CSCO
$457B
| $1.89M | 1.08% |
+77,550
| New | +$1.75M |
|
41
SLB Ltd
SLB
$73.6B
| $1.88M | 1.08% |
+26,185
| New | +$1.94M |
|
42
DuPont de Nemours
DD
$18.5B
| $1.83M | 1.05% |
+22,488
| New | +$1.9M |
|
43
Oracle
ORCL
$374B
| $1.79M | 1.03% |
+58,250
| New | +$1.93M |
|
44
Devon Energy
DVN
$52.1B
| $1.66M | 0.95% |
+31,950
| New | +$1.78M |
|
45
Weyerhaeuser
WY
$18B
| $1.66M | 0.95% |
+58,165
| New | +$1.76M |
|
46
Sonoco
SON
$5.57B
| $1.58M | 0.9% |
+45,599
| New | +$1.59M |
|
|
TWX
47
DELISTED
Time Warner Inc
TWX
| $1.54M | 0.88% |
+27,807
| New | +$1.57M |
|
48
Exelon
EXC
$47.2B
| $1.53M | 0.88% |
+69,573
| New | +$1.69M |
|
49
VeriSign
VRSN
$26.2B
| $1.48M | 0.85% |
+33,050
| New | +$1.53M |
|
50
Allstate
ALL
$68B
| $1.43M | 0.82% |
+29,620
| New | +$1.44M |
|
Similar funds
GCP
AWA
WC
LAM
FFA
VW
1CP
NC
Argyle Capital Management's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Argyle Capital Management, which disclosed 108 positions worth $174M. Its ten largest holdings account for 25% of the portfolio.
Its largest position is Pfizer: 177,740 shares worth $4.72M.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, followed by Technology and Industrials.
- Argyle Capital Management's largest Q2 2013 buy was Pfizer: 177,740 shares worth $4.72M.
- Argyle Capital Management's ten largest holdings make up 25% of its $174M portfolio in Q2 2013.
- Argyle Capital Management disclosed 108 positions in Q2 2013, its first 13F filing on record.
Based on Argyle Capital Management's 13F filing for Q2 2013, filed 31 Jul 2013.